202 related articles for article (PubMed ID: 36423475)
1. Cardiovascular Health by Graves' Disease Management Modality - Surgery Versus Radioactive Iodine Versus Antithyroid Medications: A Network Meta-Analysis.
Issa PP; Hussein M; Omar M; Munshi R; Attia AS; Buti Y; Aboueisha M; Shama M; Toraih E; Kandil E
J Surg Res; 2023 Mar; 283():266-273. PubMed ID: 36423475
[TBL] [Abstract][Full Text] [Related]
2. Total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
Ma EZ; Kuo JH; Malek R; Turner DJ; Olson JA; Slejko JF; Mullins CD; Hu Y
Surgery; 2023 Jan; 173(1):193-200. PubMed ID: 36208983
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Outcomes of Thyroidectomy or Radioactive Iodine Ablation for Graves' Disease.
Gibson A; Dave A; Johnson C; Kotwal A; Fingeret AL
J Surg Res; 2020 Dec; 256():486-491. PubMed ID: 32798996
[TBL] [Abstract][Full Text] [Related]
4. A comparison of cardiovascular disease, cancer, mortality, and Graves' ophthalmopathy following treatment for hyperthyroidism: A Bayesian network meta-analysis.
Liu X; Wong CKH; Wu T; Chan WWL; Woo YC; Lam CLK; Lang BHH
World J Surg; 2024 Feb; 48(2):393-407. PubMed ID: 38686801
[TBL] [Abstract][Full Text] [Related]
5. Management of Graves' hyperthyroidism: present and future.
Bartalena L; Piantanida E; Gallo D; Ippolito S; Tanda ML
Expert Rev Endocrinol Metab; 2022 Mar; 17(2):153-166. PubMed ID: 35287535
[TBL] [Abstract][Full Text] [Related]
6. Patterns of Use, Efficacy, and Safety of Treatment Options for Patients with Graves' Disease: A Nationwide Population-Based Study.
Brito JP; Payne S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Iñiguez-Ariza NM; Montori VM; Stan MN
Thyroid; 2020 Mar; 30(3):357-364. PubMed ID: 31973681
[No Abstract] [Full Text] [Related]
7. Outcomes of Graves' Disease Patients Following Antithyroid Drugs, Radioactive Iodine, or Thyroidectomy as the First-line Treatment.
Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Lam CLK; Lang BHH
Ann Surg; 2021 Jun; 273(6):1197-1206. PubMed ID: 33914484
[TBL] [Abstract][Full Text] [Related]
8. Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review.
Acharya SH; Avenell A; Philip S; Burr J; Bevan JS; Abraham P
Clin Endocrinol (Oxf); 2008 Dec; 69(6):943-50. PubMed ID: 18429949
[TBL] [Abstract][Full Text] [Related]
9. Management of Graves Disease: A Review.
Burch HB; Cooper DS
JAMA; 2015 Dec; 314(23):2544-54. PubMed ID: 26670972
[TBL] [Abstract][Full Text] [Related]
10. Does thyroidectomy, radioactive iodine therapy, or antithyroid drug treatment alter reactivity of patients' T cells to epitopes of thyrotropin receptor in autoimmune thyroid diseases?
Soliman M; Kaplan E; Abdel-Latif A; Scherberg N; DeGroot LJ
J Clin Endocrinol Metab; 1995 Aug; 80(8):2312-21. PubMed ID: 7543112
[TBL] [Abstract][Full Text] [Related]
11. Use of cold iodine in patients with Graves' disease: observations from a clinical practice.
Hao ST; Reasner CA; Becker RA
Endocr Pract; 2001; 7(6):438-42. PubMed ID: 11747279
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of patients treated with antithyroid drugs, radioactive iodine or surgery for persistent or relapsed Graves' disease.
Liu X; Wong CKH; Chan WWL; Tang EHM; Woo YC; Liu SYW; Lam CLK; Lang BHH
Br J Surg; 2022 Mar; 109(4):381-389. PubMed ID: 35136950
[TBL] [Abstract][Full Text] [Related]
13. Impaired Quality of Life After Radioiodine Therapy Compared to Antithyroid Drugs or Surgical Treatment for Graves' Hyperthyroidism: A Long-Term Follow-Up with the Thyroid-Related Patient-Reported Outcome Questionnaire and 36-Item Short Form Health Status Survey.
Törring O; Watt T; Sjölin G; Byström K; Abraham-Nordling M; Calissendorff J; Cramon PK; Filipsson Nyström H; Hallengren B; Holmberg M; Khamisi S; Lantz M; Wallin G
Thyroid; 2019 Mar; 29(3):322-331. PubMed ID: 30667296
[TBL] [Abstract][Full Text] [Related]
14. The effect of propylthiouracil on subsequent radioactive iodine therapy in Graves' disease.
Hancock LD; Tuttle RM; LeMar H; Bauman J; Patience T
Clin Endocrinol (Oxf); 1997 Oct; 47(4):425-30. PubMed ID: 9404440
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of single-session radiofrequency ablation (RFA) in rendering euthyroidism for persistent/relapsed Graves' disease, a pilot study.
Fung MHM; Lang BHH
Eur Radiol; 2023 Sep; 33(9):6534-6544. PubMed ID: 37036479
[TBL] [Abstract][Full Text] [Related]
16. Definitive treatment of Graves' disease in children and adolescents.
Król A; Czarniecka A; Jarząb B
Endokrynol Pol; 2021; 72(6):661-665. PubMed ID: 34855196
[TBL] [Abstract][Full Text] [Related]
17. Critical appraisal of total thyroidectomy is more cost-effective than radioactive iodine as an alternative to antithyroid medication for Graves' disease.
Thakur PS; Kumar C
Surgery; 2023 May; 173(5):1311. PubMed ID: 36528405
[No Abstract] [Full Text] [Related]
18. Comparative Effectiveness of Treatment Choices for Graves' Hyperthyroidism: A Historical Cohort Study.
Sundaresh V; Brito JP; Thapa P; Bahn RS; Stan MN
Thyroid; 2017 Apr; 27(4):497-505. PubMed ID: 28049375
[TBL] [Abstract][Full Text] [Related]
19. Surgical treatment of Graves' disease: evidence-based approach.
Stålberg P; Svensson A; Hessman O; Akerström G; Hellman P
World J Surg; 2008 Jul; 32(7):1269-77. PubMed ID: 18327526
[TBL] [Abstract][Full Text] [Related]
20. Revisiting the role of surgery in the treatment of Graves' disease.
Cohen O; Ronen O; Khafif A; Rodrigo JP; Simo R; Pace-Asciak P; Randolph G; Mikkelsen LH; Kowalski LP; Olsen KD; Sanabria A; Tufano RP; Babighian S; Shaha AR; Zafereo M; Ferlito A
Clin Endocrinol (Oxf); 2022 Jun; 96(6):747-757. PubMed ID: 34954838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]